Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit ... - Stock Titan

Summary

The article discusses Scinai Immunotherapeutics' expansion into the U.S. with a new subsidiary focused on contract manufacturing for biotech, particularly drug manufacturing. It highlights growing demand and regulatory challenges in this sector. Tags connect to key topics like Laurus Labs and geographical locations relevant to Scinai's operations.